No record found
No record found
No record found
capitalstake.com. Provided by * Returns not adjusted for payouts
^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.
Company Profile
Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was converted into a public limited company on 08 September 1960. The Company is primarily engaged in the imports, manufacture and sale of pharmaceutical products and medical devices.
| Osman Khalid Waheed | CEO |
| Amna Piracha Khan | Chairperson |
| Syed Ghausuddin Saif | Company Secretary |
Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.
CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore
KPMG Taseer Hadi & Co. Chartered Accountants
June
Equity Profile
Announcements
| Date | Title | Document |
|---|---|---|
| Sep 29, 2026 | Financial Results for the Year Ended 2026-06-30 | View PDF |
| Apr 30, 2026 | Transmission of Quarterly Report for the Period Ended 31-03-2026 | View PDF |
| Apr 29, 2026 | Financial Results for the Quarter Ended 31-03-2026 | View PDF |
| Feb 27, 2026 | Transmission of Quarterly Financial Statements for the Period Ended 31-12-2025 | View PDF |
| Feb 26, 2026 | Financial Results for the Quarter Ended 31-12-2025 | View PDF |
| Date | Title | Document |
|---|---|---|
| Sep 17, 2026 | Material Information | View PDF |
| Jul 15, 2026 | Approval of Annual Budget for FY 2026-27 | View |
| Jul 15, 2026 | Appointment of Chairperson and Chief Executive Officer | View |
| Jul 3, 2026 | Certified True Copy of Resolution passed by the Shareholders in EOGM of the Company held on July 03, 2026 | View PDF |
| Jun 24, 2026 | Election of Directors | View PDF |
Financials
All numbers in thousands (000's) except EPS
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Sales | 15,757,024 | 13,857,967 | 12,711,714 | 9,893,391 |
| Profit after Taxation | 650,902 | 528,243 | 400,054 | 189,042 |
| EPS | 14.97 | 12.15 | 9.20 | 4.35 |
| Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | |
|---|---|---|---|---|
| Sales | 3,659,686 | 4,405,781 | 3,883,252 | 3,778,689 |
| Profit after Taxation | 150,250 | 171,195 | 182,420 | 138,117 |
| EPS | 3.46 | 3.93 | 4.20 | 3.18 |

Ratios
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Gross Profit Margin (%) | 42.05 | 41.27 | 38.88 | 38.63 |
| Net Profit Margin (%) | 4.13 | 3.81 | 3.15 | 1.91 |
| EPS Growth (%) | 23.21 | 32.07 | 111.49 | (63.23) |
| PEG | 1.16 | 1.00 | 0.24 | (0.50) |









Feedback
Terms of Use
https://www.psx.com.pk